Showing 1 to 3
Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial.
Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.
The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit-hyperactivity disorder.
International Clinical Psychopharmacology
Publications Database |
Rate This Page
Print This Page / view All
Back to top